Why Novo Nordisk (NVO) Is Among the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best socially responsible stocks to buy according to hedge funds.

Socially responsible companies are businesses that integrate social and environmental considerations into their core operations and decision-making processes. One of the key characteristics of socially responsible companies is their focus on environmental stewardship and they actively work to reduce their environmental impact by implementing sustainable practices, reducing waste, conserving resources, and minimizing carbon emissions.

Another important aspect of socially responsible companies is their focus on social equity. These companies promote fair labor practices, support community development, and respect human rights. This includes providing fair wages, safe working conditions, and opportunities for employee growth and development.

Ethical governance is also a cornerstone of socially responsible companies. They maintain high standards of transparency, accountability, and integrity in their operations and decision-making processes. This includes ethical business practices, fair competition, and responsible marketing.

Investors are drawn to socially responsible companies because of the alignment with their personal values. Many investors are driven by a desire to make a positive impact on society. By investing in socially responsible companies, they can support businesses that share their values and contribute to social and environmental causes they care about.

READ ALSO: 12 Cheapest Stocks with Biggest Upside Potential and Top 10 Undervalued Tech Stocks to Buy According to Hedge Funds.

The global shift toward sustainable investing is gaining significant traction. The Sustainability Megatrends Report by Cushman & Wakefield highlighted that 60% of global investors reported higher performance yields from Environmental, Social, and Governance (ESG) investments. This positive financial outcome is driving a surge in demand for ESG funds, with 78% of investors willing to pay higher fees for these products. One of the most significant trends is that Institutional investors are increasingly recognizing the financial advantages of ESG-focused investments, leading to a transformation in how companies allocate capital. Therefore, strong ESG performance is becoming a critical factor in attracting investment, with companies that excel in this area seeing a surge in capital inflows.

Mandatory ESG reporting is another critical trend, as governments and regulators worldwide are enforcing greater transparency in environmental and social impact metrics. Companies that integrate these reporting standards into their strategies are better positioned to manage risks and seize new opportunities. The global energy transition and decarbonization efforts are also reshaping industries, with companies investing heavily in renewable energy and implementing strategies to reduce their carbon footprints.

Investors are increasingly drawn to socially responsible companies due to the potential for risk mitigation, long-term value, and alignment with personal values.

Why Novo Nordisk A/S (NVO) Is One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

An elderly couple receiving insulin from a pharmacist, representing healthcare company’s successful pharmaceutical products.

Our Methodology

To compile our list of the 8 best socially responsible stocks to buy according to hedge funds, we sifted through internet rankings to find 20 socially responsible companies. We then used Insider Monkey’s Hedge Fund database to rank 8 stocks according to the largest number of hedge fund holders, as of Q3 2024. The list is sorted in ascending order of hedge fund sentiment.

Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Investors: 61

Novo Nordisk A/S (NYSE:NVO) is a global leader in diabetes care and chronic disease management. The company develops insulin therapies, GLP-1 medications, and treatments for obesity and rare endocrine disorders. Novo Nordisk A/S (NYSE:NVO) promotes health equity and responsible healthcare practices by making medications affordable and accessible.

Novo Nordisk A/S’s (NYSE:NVO) GLP-1 treatments, including Ozempic and Wegovy, have seen substantial sales growth, driven by their effectiveness in managing blood glucose levels and promoting weight loss. To further capitalize on this success, the company is investing heavily in scaling its supply chain to meet the high demand for these treatments. Novo Nordisk A/S (NYSE:NVO) has tripled its patient reach in the past three years, now serving over 11.5 million patients globally. Additionally, the company is expanding its GLP-1 portfolio with new formulations and indications, such as the oral semaglutide and the 2.4 mg dose for obesity, to cater to a broader patient base and address unmet medical needs.

Novo Nordisk A/S (NYSE:NVO) is also actively working to improve market access and patient support. In the U.S., the company has secured coverage for Wegovy for over 55 million people living with obesity. Internationally, Novo Nordisk A/S (NYSE:NVO) is launching Wegovy in more than 15 countries and is committed to re-establishing supply for its rare endocrine disorder products. The company is also investing in patient education and support programs to help individuals manage their conditions effectively.

Overall, NVO ranks 8th on our list of the best socially responsible stocks to buy according to hedge funds. While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NVO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.